Early administration of branched-chain amino acid granules

doi:10.3748/wjg.v18.i33.4486

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 18, Issue 33

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (4455)

All Articles published online

The chart showing PDF series, HTML series, Tables (1-1) series.

Item

Count

PDF

446

HTML

3784

Tables (1-1)

225

Sum=4455

Sep 7, 2012 (publication date) through Dec 26, 2024

Times Cited of This Article

Times Cited (12)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Topic Highlight

World J Gastroenterol. Sep 7, 2012; 18(33): 4486-4490
Published online Sep 7, 2012. doi: 10.3748/wjg.v18.i33.4486

Early administration of branched-chain amino acid granules

Toru Ishikawa

Toru Ishikawa, Department of Gastroenterology and Hepatology, Saiseikai Niigata Daini Hospital, Niigata 950-1104, Japan

Author contributions: Ishikawa T contributed solely to this review.

Correspondence to: Toru Ishikawa, MD, PhD, Department of Gastroenterology and Hepatology, Saiseikai Niigata Daini Hospital, 280-7 Teraji, Niigata 950-1104, Japan. toruishi@ngt.saiseikai.or.jp

Telephone: +81-25-2336161 Fax: +81-25-2338880

Received: March 11, 2012
Revised: May 21, 2012
Accepted: May 26, 2012
Published online: September 7, 2012

Abstract

The effect of malnutrition on survival in patients with decompensated liver cirrhosis has not been well defined. Nutritional intervention with branched-chain amino acid (BCAA) can increase serum albumin concentration in patients with decompensated cirrhosis but its effects on survival are unclear. The BCAA to tyrosine ratio (BTR) is a surrogate marker (the normal range of BTR is between 4.41 and 10.05, and a Fischer’s ratio of 1.8 corresponds to a BTR of 3.5) in patients with decompensated liver cirrhosis, and BCAA inhibits hepatic carcinogenesis in patients with compensated cirrhosis. This review discusses data regarding the effect of early administration of BCAA granules based on the ratio of BCAA to BTR on prognosis in patients with cirrhosis.

Keywords: Branched-chain amino acid to tyrosine ratio; Branched-chain amino acid granules; Liver cirrhosis; Nutritional intervention; Malnutrition; Quality of life; Albumin; Cancer onset